InvestSMART

CSL Limited (ASX: CSL) - Announcements

Current share price for CSL : $200.280 2.12 (1.05%)+

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$96,677 Appendix 3G 11 Sep 2020 3:38PM $284.030 $201.460 fallen by 29.07%
$96,677 Change of Director's Interest Notice 11 Sep 2020 3:38PM $284.030 $201.460 fallen by 29.07%
$96,677 Appendix 2A 7 Sep 2020 10:28AM $281.380 $201.460 fallen by 28.40%
$96,677 Appendix 3G 7 Sep 2020 10:17AM $281.160 $201.460 fallen by 28.35%
$96,677 Agreements to Manufacture COVID-19 Vaccines 7 Sep 2020 8:21AM $279.050 $201.460 fallen by 27.81%
$96,677 Shareholder Pack 2020 4 Sep 2020 8:32AM $290.950 $201.460 fallen by 30.76%
$96,677 Appendix 4G 4 Sep 2020 8:31AM $290.950 $201.460 fallen by 30.76%
$96,677 Notice of Annual General Meeting 4 Sep 2020 8:29AM $290.950 $201.460 fallen by 30.76%
$96,677 Annual Report to shareholders 4 Sep 2020 8:29AM $290.950 $201.460 fallen by 30.76%
$96,677 Change of Director's Interest Notice 2 Sep 2020 4:09PM $287.500 $201.460 fallen by 29.93%
$96,677 Change of Director's Interest Notice 2 Sep 2020 4:05PM $287.500 $201.460 fallen by 29.93%
$96,677 Appendix 2A 2 Sep 2020 4:03PM $287.500 $201.460 fallen by 29.93%
$96,677 Change of Director's Interest Notice 28 Aug 2020 4:58PM $289.890 $201.460 fallen by 30.50%
$96,677 Change of Director's Interest Notice 28 Aug 2020 4:56PM $289.890 $201.460 fallen by 30.50%
$96,677 Appendix 3G 28 Aug 2020 4:55PM $289.890 $201.460 fallen by 30.50%
$96,677 Appendix 2A 27 Aug 2020 3:45PM $293.020 $201.460 fallen by 31.25%
$96,677 Appendix 2A 21 Aug 2020 1:02PM $296.220 $201.460 fallen by 31.99%
$96,677 Initial Director's Interest Notice 19 Aug 2020 12:27PM $316.620 $201.460 fallen by 36.37%
$96,677 CSL Results Presentation 19 Aug 2020 8:18AM $293.290 $201.460 fallen by 31.31%
$96,677 Dividend/Distribution - CSL 19 Aug 2020 8:15AM $293.290 $201.460 fallen by 31.31%
$96,677 CSL Results Announcement 19 Aug 2020 8:12AM $293.290 $201.460 fallen by 31.31%
$96,677 Statutory Accounts for the Full Year Ended 30 June 2020 19 Aug 2020 8:12AM $293.290 $201.460 fallen by 31.31%
$96,677 ASX Notice of Full Year Results Briefing 2020 11 Aug 2020 8:34AM $279.520 $201.460 fallen by 27.93%
$96,677 CSL Appoints New Non Executive Director 16 Jul 2020 8:15AM $287.330 $201.460 fallen by 29.89%
$96,677 CSL to acquire LateStage Gene Therapy Candidate from uniQure 25 Jun 2020 8:20AM $292.360 $201.460 fallen by 31.09%

551 - 575 of 1201 results

Page 23 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.